Deubiquitinase CYLD acts as a negative regulator for bacterium NTHi-induced inflammation by suppressing K63-linked ubiquitination of MyD88

Byung Cheol Lee, Masanori Miyata, Jae Hyang Lim, Jian Dong Li

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Myeloid differentiation factor 88 (MyD88) acts as a crucial adaptor molecule for Toll-like receptors (TLRs) and interleukin (IL)-1 receptor signaling. In contrast to the well-studied positive regulation of MyD88 signaling, how MyD88 signaling is negatively regulated still remains largely unknown. Here, we demonstrate for the first time to our knowledge that MyD88 protein undergoes lysine 63 (K63)-linked polyubiquitination, which is functionally critical for mediating TLR-MyD88-dependent signaling. Deubiquitinase CYLD negatively regulates MyD88-mediated signaling by directly interacting with MyD88 and deubiquitinating nontypeable Haemophilus influenzae (NTHi)-induced K63-linked polyubiquitination of MyD88 at lysine 231. Importantly, we further confirmed this finding in the lungs of mice in vivo by using MyD88-/-CYLD-/- mice. Understanding how CYLD deubiquitinates K63-linked polyubiquitination of MyD88 may not only bring insights into the negative regulation of TLR-MyD88-dependent signaling, but may also lead to the development of a previously unidentified therapeutic strategy for uncontrolled inflammation.

Original languageEnglish
Pages (from-to)E165-E171
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number2
DOIs
StatePublished - 12 Jan 2016

Keywords

  • CYLD
  • Deubiquitinase
  • MyD88
  • Polyubiquitination

Fingerprint

Dive into the research topics of 'Deubiquitinase CYLD acts as a negative regulator for bacterium NTHi-induced inflammation by suppressing K63-linked ubiquitination of MyD88'. Together they form a unique fingerprint.

Cite this